322 related articles for article (PubMed ID: 27932471)
1. A Paradigm Shift Is Needed in the Field of Pulmonary Arterial Hypertension for Its Entrance Into the Precision Medicine Era.
Gurtu V; Michelakis ED
Circ Res; 2016 Dec; 119(12):1276-1279. PubMed ID: 27932471
[No Abstract] [Full Text] [Related]
2. Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.
Austin ED; West J; Loyd JE; Hemnes AR
Am J Respir Crit Care Med; 2017 Jan; 195(1):23-31. PubMed ID: 27398627
[No Abstract] [Full Text] [Related]
3. A Strategy for Genomic Research on Common Cardiovascular Diseases Aiming at the Realization of Precision Medicine: Personal Insights and Perspectives.
Morita H; Komuro I
Circ Res; 2016 Sep; 119(8):900-3. PubMed ID: 27688306
[No Abstract] [Full Text] [Related]
4. Sex bias in trials and treatment must end.
Kim AM; Tingen CM; Woodruff TK
Nature; 2010 Jun; 465(7299):688-9. PubMed ID: 20535184
[No Abstract] [Full Text] [Related]
5. Cancer genomics and clinical practice: how can we close the gap more quickly?
Konecny GE
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):1-3. PubMed ID: 27941363
[No Abstract] [Full Text] [Related]
6. Covert Brain Infarction: Towards Precision Medicine in Research, Diagnosis, and Therapy for a Silent Pandemic.
Meinel TR; Kaesmacher J; Roten L; Fischer U
Stroke; 2020 Aug; 51(8):2597-2606. PubMed ID: 32646332
[No Abstract] [Full Text] [Related]
7. New and Emerging Therapies for Pulmonary Arterial Hypertension.
Spiekerkoetter E; Kawut SM; de Jesus Perez VA
Annu Rev Med; 2019 Jan; 70():45-59. PubMed ID: 30216732
[TBL] [Abstract][Full Text] [Related]
8. Epilepsy research in 2016: new treatment directions.
Berkovic SF
Lancet Neurol; 2017 Jan; 16(1):7-9. PubMed ID: 27979357
[No Abstract] [Full Text] [Related]
9. Exploiting microRNA Specificity and Selectivity: Paving a Sustainable Path Towards Precision Medicine.
Santulli G
Adv Exp Med Biol; 2015; 888():1-3. PubMed ID: 26663175
[TBL] [Abstract][Full Text] [Related]
10. [Emphasis on the application of precision medicine in ophthalmology].
Sun XD; Zhu H
Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):85-8. PubMed ID: 26906701
[TBL] [Abstract][Full Text] [Related]
11. 4 Ds in health research-working together toward rapid precision medicine.
Niederberger E; Parnham MJ; Maas J; Geisslinger G
EMBO Mol Med; 2019 Nov; 11(11):e10917. PubMed ID: 31531943
[TBL] [Abstract][Full Text] [Related]
12. Scientific Discovery, Contextual Factors, and Cardiometabolic Health Research: Back to the Future.
Siscovick DS
Circ Res; 2017 May; 120(10):1555-1557. PubMed ID: 28495992
[No Abstract] [Full Text] [Related]
13. [Pulmonary (Arterial) Hypertension].
Kwapiszewska G; Hoffmann J; Kovacs G; Stacher E; Olschewski A; Olschewski H
Pneumologie; 2016 Oct; 70(10):630-637. PubMed ID: 27050448
[TBL] [Abstract][Full Text] [Related]
14. Myocardial Infarction as a Clinical End Point in Research.
DeFilippis AP; Nasir K; Blaha MJ
Circ Res; 2019 Jun; 124(12):1701-1703. PubMed ID: 31170039
[No Abstract] [Full Text] [Related]
15. Personalized medicine: Time for one-person trials.
Schork NJ
Nature; 2015 Apr; 520(7549):609-11. PubMed ID: 25925459
[No Abstract] [Full Text] [Related]
16. Integrating Personalized Medicine in the Canadian Environment: Efforts Facilitating Oncology Clinical Research.
Syme R; Carleton B; Leyens L; Richer E
Public Health Genomics; 2015; 18(6):372-80. PubMed ID: 26565702
[TBL] [Abstract][Full Text] [Related]
17. Clinical Trials in the Evolving Landscape of Precision Medicine.
Cancer Cell; 2020 Jul; 38(1):3-8. PubMed ID: 32663468
[TBL] [Abstract][Full Text] [Related]
18. Clinical advances in pulmonary arterial hypertension: the year in review.
Bartolome SD
Curr Opin Pulm Med; 2013 Sep; 19(5):430-6. PubMed ID: 23907455
[TBL] [Abstract][Full Text] [Related]
19. The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?
Weatherald J; Boucly A; Sahay S; Humbert M; Sitbon O
Am J Respir Crit Care Med; 2018 Apr; 197(7):860-868. PubMed ID: 29256625
[No Abstract] [Full Text] [Related]
20. Using Clinical Trial End Points to Risk Stratify Patients With Pulmonary Arterial Hypertension.
Waxman AB; Farber HW
Circulation; 2015 Dec; 132(22):2152-61. PubMed ID: 26621638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
